Region — International. Neutral scientific reference — not offered for sale here.

Set region

Explore Shop Tools Journal Trust

Explore  /  Tea Tree Oil

Research reference — not for sale

Tea Tree Oil

C

lead outcome

Topical (skin, around 5%): appearance of…

grades vary by outcome ↓

Blend / combination

also called — melaleuca oil · Melaleuca alternifolia oil · TTO

skin conditioning (cosmetic)blemish-prone skin (appearance)fragrance

Safety

Every trial supporting this ingredient used it at around 5% in a formulated gel. The common home practice of dabbing the neat oil onto skin is not what was tested, and undiluted essential oil can cause irritation and contact dermatitis. Use a finished product at a sensible concentration or dilute properly, patch test first, and replace oil that has aged or been stored in heat or light.

This is an independent evidence reference. Vallydia does not sell a tea tree oil product. Nothing here is medical advice; persistent, cystic or severe acne is a matter for a doctor.

In brief

One of the very few botanicals in this register that arrived with randomised trials behind it rather than tradition. A 5% gel reduced blemish counts comparably to 5% benzoyl peroxide in a 124-participant comparison, more slowly but with fewer side effects, and beat placebo convincingly in a later double-blind trial. The evidence is genuinely better than most natural remedies ever manage and still thin in absolute terms: the trials are small and old, and 2024 dermatology guidance holds them insufficient for a formal recommendation. The more useful caution is about practice rather than proof. Every supporting trial used around 5% in a formulated gel, while the ingredient is mostly used at home as neat oil straight from the bottle, and neat essential oil causes irritation and contact dermatitis. Oxidised oil is more sensitising again, so storage matters. Read it as a slow, gentle, properly diluted option for mild blemishes, not as a spot treatment and not as a substitute for medicine.

Legal standing, by region

International

Lawful cosmetic ingredient

Lawful as a cosmetic ingredient across major markets, including the EU and UK under Regulation (EC) No 1223/2009 as retained, and the United States. As with other essential oils, the practical constraints are on concentration and on claims rather than on the substance: presenting a product as treating acne moves it out of the cosmetic category and into medicinal regulation.

Evidence, by outcome

How we grade →

An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.

OutcomeEvidence base · effectGrade

Topical (skin, around 5%): appearance of mild inflammatory blemishes

Onset is slow, in the region of four to six weeks against roughly two for benzoyl peroxide. The trials are small, old and one was only single-blind, and dermatology guidance published in 2024 holds the overall evidence insufficient to formally recommend it. Unusually good for a botanical, and still a thin evidence base in absolute terms.

Two randomised trials: a single-blind comparison of 5% tea tree oil gel against 5% benzoyl peroxide lotion in 124 participants over three months (Bassett 1990), and a double-blind placebo-controlled trial of a 5% gel over 45 days (Enshaieh 2007), alongside review literature. · Reduced counts of both inflamed and non-inflamed lesions. Against placebo the gel was reported as several times more effective on total lesion count and on severity score; against benzoyl peroxide the effect was comparable in size.

C

Topical (skin): tolerability compared with benzoyl peroxide

Gentler than a comparator known for irritation is a low bar, and tea tree oil has its own irritant and allergenic potential. The favourable tolerability holds for a properly formulated product, not for the neat oil.

Direct within-trial comparison of adverse effects in the 1990 study, where both preparations were applied twice daily over three months. · Fewer and milder side effects than the benzoyl peroxide comparator, with less scaling, dryness and stinging reported.

B

Common practice: applying the undiluted oil directly to skin

This is the most common way the ingredient is actually used at home and the concentration used in every supporting trial was 5%. Sensitisation, once established, does not reverse.

Irritancy and allergenicity testing in human subjects, and the review literature on tea tree oil composition and oxidation. · Neat application causes irritation and contact dermatitis in a meaningful proportion of users, and oil that has oxidised through age, heat or light exposure is appreciably more sensitising than fresh oil.

D

Marketing claim: a natural alternative to acne medication

Relying on it for severe presentations risks leaving something undertreated. This is a cosmetic reference; anything persistent or severe is a matter for a doctor.

Marketing claim. · The evidence covers mild to moderate inflammatory lesions only. Nothing supports the ingredient for cystic or severe presentations, and no trial positions it as a replacement for retinoids or prescribed treatment.

D

Safety (in finished cosmetic products at typical concentrations)

A recognised contact allergen for some people, and patch testing before regular use is sensible. Storage matters more than for most ingredients, since oxidised oil is the more sensitising form.

Long-standing cosmetic use across skin and hair categories, alongside the review literature on its antimicrobial and irritant profile. · Well tolerated in finished formulations at the low percentages ordinarily used.

—

Disclosure

Vallydia sells its own cosmetic serums, and some ingredients graded here belong to the same categories as those products. Grades are drawn from the published evidence by the method we publish, and applied to our own ingredients on the same terms — our copper-peptide serum is graded no more kindly than the peptides it competes with. We disclose the interest so you can weigh it.

Trade names shown here (for example Matrixyl, Argireline, Syn-Ake) are the property of their respective owners and are used only to identify the ingredient under discussion. Their appearance implies no affiliation with, or endorsement by, the proprietor.

Evidence changes

Get notified if this changes

We track new research and update these grades as the evidence moves. Leave your email and we'll tell you if the evidence for Tea Tree Oil changes - nothing else.

Cosmetic claims boundary

✓ Allowed (appearance / feel)

helps reduce the appearance of blemishes on blemish-prone skin
a gentler option than harsher blemish actives for some people
a plant oil used in skin and scalp products

✕ Not allowed (medicinal)

treats acne
cures breakouts
a natural alternative to acne medication
antibacterial treatment
safe to apply undiluted

The medicinal-sounding science stays in the reference section; product copy speaks only to appearance/feel (Reg 655/2013). Different fields, never merged.

The honest part

Tea tree oil is one of the few botanicals in this register that arrived with actual randomised trials rather than tradition, and it deserves credit for that. The gap worth naming is not between the claim and the evidence but between the evidence and the practice: the studies tested a 5% formulated gel, while the ingredient is overwhelmingly used at home as neat oil from a small bottle. The version people apply is not the version that was tested, and it is the version that causes the reactions.

Not the same as its namesake

This card grades the essential oil of *Melaleuca alternifolia* specifically. Other Melaleuca species appear in cosmetics under their own INCI names, including cajuput and niaouli oils, and they differ in composition; the evidence here does not extend to them. Freshness is a second, less obvious non-equivalence: oxidised tea tree oil is not chemically the same material as fresh oil and is more sensitising, so the safety profile assumed by these grades applies to properly stored product.

Identity

Tea Tree Oil is the essential oil steam-distilled from the leaves of Melaleuca alternifolia, a tree native to the Australian east coast. It is a mixture of terpenes rather than a single molecule, and its principal active constituent is terpinen-4-ol, which carries the antimicrobial and anti-inflammatory activity the ingredient is used for.

Composition is not fixed. It varies by chemotype, harvest and, importantly, by age: the oil oxidises on exposure to air, heat and light, and the oxidation products are more irritating than the fresh oil.

Development & history

Tea tree oil has a long history as a topical antiseptic in Australia, but until 1990 that history was anecdotal. The Medical Journal of Australia trial that year was the first proper clinical test, comparing a 5% gel against 5% benzoyl peroxide in 124 people over three months, and it moved the ingredient from folk remedy into the category of botanicals with data.

A double-blind placebo-controlled trial followed in 2007, reporting a substantially better result for the 5% gel than placebo on both lesion count and severity scoring. Review literature since has been consistent in direction and consistent in its qualification: the effect is real, the trials are few, and the evidence base has not grown in proportion to the ingredient's popularity.

Mechanism (as proposed)

The proposed mechanism is straightforward and unusually well grounded for a plant extract. Terpinen-4-ol disrupts bacterial cell membranes, giving broad antimicrobial activity, and the oil also shows anti-inflammatory effects in laboratory work. Applied to blemish-prone skin, both actions point the same direction: less bacterial activity in the follicle and less inflammatory response around it.

What the mechanism does not explain is the slow onset. Four to six weeks is a long lag for an antimicrobial effect, and it suggests that whatever produces the visible result is not simply bacterial suppression happening quickly.

Related reading

Our journal article examines the acne evidence in full, including how it compares with the faster and better-evidenced options. See also our writing on how to read botanical claims generally, where this ingredient is the exception rather than the rule.

Scan your productSee if Tea Tree Oil is in what you're usingOpen the scanner →

Sources — 4 cited

01Bassett IB, Pannowitz DL, Barnetson RS. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Medical Journal of Australia. 1990;153(8):455-458.

02Enshaieh S, Jooya A, Siadat AH, Iraji F. The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study. Indian Journal of Dermatology, Venereology and Leprology. 2007;73(1):22-25.

03Hammer KA. Treatment of acne with tea tree oil (melaleuca) products: a review of efficacy, tolerability and potential modes of action. International Journal of Antimicrobial Agents. 2015;45(2):106-110.

04Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clinical Microbiology Reviews. 2006;19(1):50-62.

Updated 2026-08-28

Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.

Related compounds

Salicylic AcidA

Small molecule (non-peptide)

Niacinamide (Vitamin B3)A

Small molecule (non-peptide)

Explore by goal

Skin & aesthetic →

A neutral reference and a lawful-lane shop. Information for those who seek it — never promotion.

Region — International

ExploreRegister The Register — full index Categories Trust & COA How we grade Open data Brands

ShopCosmetic peptides Journal Quizzes

TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia.